Ontology highlight
ABSTRACT:
SUBMITTER: Farkkila A
PROVIDER: S-EPMC7081234 | biostudies-literature | 2020 Mar
REPOSITORIES: biostudies-literature
Färkkilä Anniina A Gulhan Doga C DC Casado Julia J Jacobson Connor A CA Nguyen Huy H Kochupurakkal Bose B Maliga Zoltan Z Yapp Clarence C Chen Yu-An YA Schapiro Denis D Zhou Yinghui Y Graham Julie R JR Dezube Bruce J BJ Munster Pamela P Santagata Sandro S Garcia Elizabeth E Rodig Scott S Lako Ana A Chowdhury Dipanjan D Shapiro Geoffrey I GI Matulonis Ursula A UA Park Peter J PJ Hautaniemi Sampsa S Sorger Peter K PK Swisher Elizabeth M EM D'Andrea Alan D AD Konstantinopoulos Panagiotis A PA
Nature communications 20200319 1
Combined PARP and immune checkpoint inhibition has yielded encouraging results in ovarian cancer, but predictive biomarkers are lacking. We performed immunogenomic profiling and highly multiplexed single-cell imaging on tumor samples from patients enrolled in a Phase I/II trial of niraparib and pembrolizumab in ovarian cancer (NCT02657889). We identify two determinants of response; mutational signature 3 reflecting defective homologous recombination DNA repair, and positive immune score as a sur ...[more]